Healthcare Industry News:  bioabsorbable 


 News Release - September 18, 2008

ENTrigue Surgical, Inc. Announces Product Commercialization

SAN ANTONIO, Sept. 18 (HSMN NewsFeed) -- ENTrigue Surgical, Inc. announces the commercial release of its initial SerpENT(TM) Articulating Instruments, the first of several innovative solutions for ENT (Ear, Nose, and Throat) surgery. The SerpENT(TM) instruments utilize a patented technology that enables instruments to bend around corners, resulting in less invasive and more efficient surgical procedures. The Company plans to commercialize several additional unique solutions for ENT procedures, including products based on absorbable polymer technologies. Fred Dinger, President and CEO of ENTrigue Surgical commented, "We believe that by listening to the surgeons in the field, we can identify opportunities for innovation in Otolaryngology. We are developing novel and practical products that simplify procedures for surgeons and improve healing for patients." ENTrigue will showcase its products and technologies in booth # 589 at the AAO-HNS/F Annual Meeting & OTO EXPO in Chicago, IL from September 21-24, 2008.

Since its inception in May 2007, ENTrigue Surgical has built a robust intellectual property portfolio with several patents issued, pending and licensed around its core technologies. The Company has also established collaborative partnerships with biomaterials innovators, such as Tepha, Inc., as well as with developers and manufacturers of unique surgical instrumentation. ENTrigue Surgical recently completed a $6.4 million Series B financing to further develop and commercialize its ground-breaking technologies. Existing shareholders and principal healthcare investors, The Vertical Group and Prism VentureWorks, led the financing.

About ENTrigue Surgical, Inc.

ENTrigue Surgical is a privately held medical device company formed with the objective of innovating and delivering next generation devices and therapies for the ENT operating room and office. Products from ENTrigue Surgical focus on enhancing surgical access for increased functionality and precision. Unique to the industry, ENTrigue Surgical is also developing a new class of clinically proven bioabsorbable and biologic implants designed to simplify surgical procedures and improve healing.

For further information on ENTrigue Surgical and its technologies, please visit or contact:

Prasad Nalluri
ENTrigue Surgical, Inc.
12672 Silicon Drive, Ste. 150
San Antonio, TX 78249
Tel: 210-298 6332

Source: ENTrigue Surgical

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.